ArticleJournal of experimental & clinical cancer research : CR2023

MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma.

Christian Bergamini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.